Literature DB >> 23538412

Genetics of Alzheimer disease.

A T Rao1, A J Degnan, L M Levy.   

Abstract

Alzheimer disease prevails as a major cause of disability in the elderly population and ranks as the most common form of dementia that affects 1 of 8 individuals older than 65 years of age. Most AD cases are late in onset and are probably influenced by both genetic and environmental factors. Apart from age, the risk factors include family history; brain injury, both traumatic and vascular; and metabolic diseases, such as diabetes, hypercholesterolemia, and obesity. Based on twin studies, inheritance plays a role in approximately 80% of cases (familial and sporadic).

Entities:  

Mesh:

Year:  2013        PMID: 23538412      PMCID: PMC7964720          DOI: 10.3174/ajnr.A3545

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  6 in total

Review 1.  Genetics of Alzheimer disease.

Authors:  Lynn M Bekris; Chang-En Yu; Thomas D Bird; Debby W Tsuang
Journal:  J Geriatr Psychiatry Neurol       Date:  2010-12       Impact factor: 2.680

Review 2.  Genetics and epigenetics of Alzheimer's disease.

Authors:  Kannayiram Alagiakrishnan; Sudeep S Gill; Andrei Fagarasanu
Journal:  Postgrad Med J       Date:  2012-04-29       Impact factor: 2.401

Review 3.  Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play.

Authors:  Clifford R Jack
Journal:  Radiology       Date:  2012-05       Impact factor: 11.105

4.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

Review 5.  Genetic aspects of Alzheimer disease.

Authors:  Jennifer Williamson; Jill Goldman; Karen S Marder
Journal:  Neurologist       Date:  2009-03       Impact factor: 1.398

Review 6.  Genetic aspects of Alzheimer disease.

Authors:  Thomas D Bird
Journal:  Genet Med       Date:  2008-04       Impact factor: 8.822

  6 in total
  15 in total

1.  Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.

Authors:  Jalal Gharesouran; Maryam Rezazadeh; Aziz Khorrami; Morteza Ghojazadeh; Mahnaz Talebi
Journal:  J Mol Neurosci       Date:  2014-07-15       Impact factor: 3.444

2.  Design and Fabrication a Gold Nanoparticle-DNA Based Nanobiosensor for Detection of microRNA Involved in Alzheimer's Disease.

Authors:  Shokoufeh Delkhahi; Mahdi Rahaie; Fereshteh Rahimi
Journal:  J Fluoresc       Date:  2016-12-01       Impact factor: 2.217

Review 3.  Intranasal drug delivery for treatment of Alzheimer's disease.

Authors:  Leonor C Fonseca; João A Lopes; João Vieira; Cláudia Viegas; Cláudia S Oliveira; Rafael P Hartmann; Pedro Fonte
Journal:  Drug Deliv Transl Res       Date:  2021-02-26       Impact factor: 4.617

4.  Elevation of peripheral BDNF promoter methylation links to the risk of Alzheimer's disease.

Authors:  Lan Chang; Yunliang Wang; Huihui Ji; Dongjun Dai; Xuting Xu; Danjie Jiang; Qingxiao Hong; Huadan Ye; Xiaonan Zhang; Xiaohui Zhou; Yu Liu; Jinfeng Li; Zhongming Chen; Ying Li; Dongsheng Zhou; Renjie Zhuo; Yuzheng Zhang; Honglei Yin; Congcong Mao; Shiwei Duan; Qinwen Wang
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

Review 5.  Exploring Relationships between Host Genome and Microbiome: New Insights from Genome-Wide Association Studies.

Authors:  Muslihudeen A Abdul-Aziz; Alan Cooper; Laura S Weyrich
Journal:  Front Microbiol       Date:  2016-10-12       Impact factor: 5.640

6.  Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease.

Authors:  Minghui Wang; Panos Roussos; Andrew McKenzie; Xianxiao Zhou; Yuji Kajiwara; Kristen J Brennand; Gabriele C De Luca; John F Crary; Patrizia Casaccia; Joseph D Buxbaum; Michelle Ehrlich; Sam Gandy; Alison Goate; Pavel Katsel; Eric Schadt; Vahram Haroutunian; Bin Zhang
Journal:  Genome Med       Date:  2016-11-01       Impact factor: 11.117

Review 7.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview.

Authors:  María Alejandra Cerquera-Jaramillo; Mauricio O Nava-Mesa; Rodrigo E González-Reyes; Carlos Tellez-Conti; Alejandra de-la-Torre
Journal:  Neural Plast       Date:  2018-10-14       Impact factor: 3.599

8.  Neuroprotective Effects of Isoquercetin: An In Vitro and In Vivo Study.

Authors:  Qingxiao Yang; Z Hichen Kang; Jingze Zhang; Fuling Qu; Bin Song
Journal:  Cell J       Date:  2021-07-17       Impact factor: 2.479

Review 9.  Induced Pluripotent Stem Cells Derived from Alzheimer's Disease Patients: The Promise, the Hope and the Path Ahead.

Authors:  Kristine Freude; Carlota Pires; Poul Hyttel; Vanessa Jane Hall
Journal:  J Clin Med       Date:  2014-12-12       Impact factor: 4.241

10.  Effects of Renal Impairment on Steady-State Plasma Concentrations of Rivastigmine: A Population Pharmacokinetic Analysis of Capsule and Patch Formulations in Patients with Alzheimer's Disease.

Authors:  Gilbert Lefèvre; Francesca Callegari; Sandro Gsteiger; Yuan Xiong
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.